LendInvest Valuation

Is 82H undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 82H when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 82H (€0.31) is trading below our estimate of fair value (€1.82)

Significantly Below Fair Value: 82H is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 82H?

Key metric: As 82H is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 82H. This is calculated by dividing 82H's market cap by their current revenue.
What is 82H's PS Ratio?
PS Ratio2x
SalesUK£18.60m
Market CapUK£37.18m

Price to Sales Ratio vs Peers

How does 82H's PS Ratio compare to its peers?

The above table shows the PS ratio for 82H vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.1x
PBB Deutsche Pfandbriefbank
1.9x12.0%€691.9m
ENGL EV Digital Invest
0.7x9.8%€3.0m
PZS Scherzer
9.8x10.0%€65.3m
EFS3 Effecten-Spiegel
4.2xn/a€48.5m
82H LendInvest
2x22.8%€37.2m

Price-To-Sales vs Peers: 82H is good value based on its Price-To-Sales Ratio (2x) compared to the peer average (4.1x).


Price to Sales Ratio vs Industry

How does 82H's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
EBEN aifinyo
0.3xn/aUS$15.51m
EBEN aifinyo
0.2xn/aUS$13.94m
CSQ creditshelf
0.005xn/aUS$29.30k
No more companies available in this PS range
82H 2.0xIndustry Avg. 2.0xNo. of Companies3PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 82H is expensive based on its Price-To-Sales Ratio (2x) compared to the European Diversified Financial industry average (1.9x).


Price to Sales Ratio vs Fair Ratio

What is 82H's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

82H PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2x
Fair PS Ratio1.9x

Price-To-Sales vs Fair Ratio: 82H is expensive based on its Price-To-Sales Ratio (2x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 82H forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.31
€0.47
+52.6%
28.2%€0.60€0.34n/a2
Nov ’25€0.29
€0.47
+59.3%
28.2%€0.60€0.34n/a2
Oct ’25€0.32
€0.47
+46.3%
28.2%€0.60€0.34n/a2
Sep ’25€0.34
€0.45
+33.6%
28.2%€0.58€0.33n/a2
Aug ’25€0.34
€1.50
+343.8%
97.9%€3.57€0.33n/a3
Jul ’25€0.33
€1.48
+355.1%
97.9%€3.53€0.33n/a3
Jun ’25€0.32
€1.47
+354.4%
97.9%€3.51€0.33n/a3
May ’25€0.31
€1.47
+371.8%
97.9%€3.51€0.33n/a3
Apr ’25€0.29
€1.47
+411.2%
97.9%€3.51€0.33n/a3
Mar ’25€0.30
€1.47
+390.7%
97.9%€3.51€0.33n/a3
Feb ’25€0.30
€1.94
+545.9%
61.6%€3.49€0.58n/a3
Jan ’25€0.30
€1.93
+552.7%
61.6%€3.48€0.58n/a3
Dec ’24€0.34
€2.15
+524.4%
46.4%€3.51€1.17n/a3
Nov ’24€0.34
€2.15
+528.1%
46.4%€3.51€1.17€0.293
Oct ’24€0.46
€2.15
+371.0%
46.4%€3.51€1.17€0.323
Sep ’24€0.54
€2.88
+438.3%
27.8%€3.50€1.75€0.343
Aug ’24€0.51
€2.88
+464.7%
27.8%€3.50€1.75€0.343
Jul ’24€0.78
€2.55
+226.4%
29.2%€3.50€1.75€0.335
Jun ’24€0.90
€2.47
+176.1%
29.2%€3.40€1.70€0.325
May ’24€0.89
€2.47
+179.2%
29.2%€3.40€1.70€0.315
Apr ’24€0.98
€2.51
+154.4%
28.2%€3.41€1.71€0.295
Mar ’24€0.98
€2.51
+154.4%
28.2%€3.41€1.71€0.305
Feb ’24€0.93
€2.51
+169.4%
28.2%€3.41€1.71€0.305
Jan ’24€0.90
€2.58
+188.5%
27.5%€3.49€1.74€0.305
Dec ’23€0.92
€2.58
+180.7%
27.5%€3.49€1.74€0.345
Nov ’23€0.97
€2.56
+162.6%
27.5%€3.46€1.73€0.345

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies